-
Remdesivir (GS-5734): Reliable Antiviral Tool for RNA Virus
2026-06-04
This article delivers an expert, scenario-driven guide to integrating Remdesivir (GS-5734), SKU B8398, into RNA virus research workflows. It addresses laboratory pain points in assay reproducibility, protocol optimization, and supplier selection, referencing validated data and current literature. Biomedical researchers can expect actionable, evidence-based insights for reliable experimental outcomes.
-
Allosteric PDK4 Inhibitors: Novel Strategies for Metabolic D
2026-06-03
This article analyzes the recent identification of novel allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, focusing on compound 8c, which demonstrates significant in vitro potency and in vivo efficacy in metabolic and allergic disease models. The findings suggest new avenues for therapeutic intervention targeting metabolic dysregulation and highlight implications for translational research.
-
BIBR 1532: Advancing Telomerase Inhibition in Translational
2026-06-03
This thought-leadership article explores the mechanistic underpinnings and translational promise of BIBR 1532 as a selective telomerase inhibitor. By integrating mechanistic insight, experimental validation, and strategic guidance, it aims to inform oncology researchers about maximizing the impact of telomerase-targeted approaches, including advanced workflows and future directions inspired by recent innovations in telomere biology.
-
Ruthenium Red: Bridging Cytoskeleton, Calcium, and Autophagy
2026-06-02
This thought-leadership article explores how cytoskeleton-dependent mechanotransduction and calcium signaling converge in autophagy research. Highlighting Ruthenium Red’s mechanistic specificity and translational potential, it offers strategic guidance for researchers navigating the evolving landscape of calcium modulation, with practical protocol insights and a forward-looking perspective.
-
Adipose-Neural Axis in Cardiac Arrhythmias: Mechanisms and M
2026-06-02
Fan et al. (2024) developed a stem cell-based coculture system to investigate how the adipose-neural axis contributes to cardiac arrhythmia, revealing a mechanistic link involving leptin and neuropeptide Y (NPY) signaling. Their findings identify new intervention targets and emphasize the complexity of adipose-cardiac-neural interactions in arrhythmogenesis.
-
Talabostat Mesylate (PT-100): Advanced Protocols for Tumor M
2026-06-01
Talabostat mesylate (PT-100) enables precise DPP4 and FAP inhibition, unlocking new experimental strategies for dissecting tumor-immune interactions and inflammasome modulation. This guide delivers actionable, data-driven workflows, comparative insights, and troubleshooting expertise to elevate research reliability and interpretability.
-
2'3'-cGAMP (Sodium Salt): Advanced Insights for cGAS-STING A
2026-06-01
Explore the unique mechanisms and advanced applications of 2'3'-cGAMP (sodium salt) in dissecting the cGAS-STING signaling pathway. This article goes beyond standard overviews to provide actionable insights for immunology and inflammation research.
-
Structural and Pharmacokinetic Distinctions of ACE Inhibitor
2026-05-31
Piepho's review dissects how angiotensin-converting enzyme (ACE) inhibitors, though sharing a common antihypertensive goal, differ in chemical structure, pharmacokinetics, and tissue targeting. The paper highlights fosinopril’s unique phosphinic acid moiety, dual elimination pathway, and high lipophilicity, providing critical guidance for model selection and translational hypertension research.
-
Triamcinolone: Technical Application in Glucocorticoid Resea
2026-05-30
Triamcinolone is a synthetic glucocorticoid agonist optimized for research applications involving glucocorticoid signaling, anti-inflammatory processes, and immunosuppression models. It is intended for in vitro studies where precise control of receptor pathways is critical but is not suitable for diagnostic or clinical use.
-
Sunitinib: Applied Workflows for Multi-Targeted RTK Inhibiti
2026-05-29
Unlock new dimensions in renal cell carcinoma and angiogenesis research with Sunitinib, a robust multi-targeted receptor tyrosine kinase inhibitor. This guide bridges the latest ferroptosis-based strategies with practical lab protocols and troubleshooting, transforming limitations of resistance into actionable opportunities.
-
TBXA2R–ERM Axis Promotes Metastatic Behavior in TNBC Cells
2026-05-29
Leguay et al. identify the thromboxane A2 receptor (TBXA2R) as a key upstream activator of ezrin, radixin, and moesin (ERM) proteins, driving the motility, invasion, and metastatic colonization of triple-negative breast cancer (TNBC) cells. This work uncovers a previously uncharacterized GPCR-dependent signaling axis central to cytoskeletal remodeling during cancer metastasis, offering new mechanistic targets for anti-metastatic intervention.
-
EGCG-Loaded 3D Printed TCP Scaffolds Enhance Bone Regenerati
2026-05-28
This study demonstrates the integration of (-)-Epigallocatechin gallate (EGCG) into three-dimensional printed tricalcium phosphate (TCP) bone scaffolds, enabling localized, sustained delivery to promote osteogenesis, suppress osteoclast maturation, and stimulate angiogenesis in vitro. The findings highlight a multifunctional strategy for repairing craniofacial bone defects after trauma or tumor excision, with translational potential for patient-specific bone graft applications.
-
Pepstatin A: Applied Aspartic Protease Inhibition Workflows
2026-05-28
Pepstatin A empowers researchers with unmatched specificity for aspartic protease inhibition, unlocking reliable viral protein processing and osteoclast differentiation studies. Discover advanced, stepwise protocols and troubleshooting insights that ensure reproducibility in both cell-based and molecular workflows.
-
NADH in Redox Regulation: Mechanistic Insights and Advanced
2026-05-27
Explore the multifaceted roles of reduced nicotinamide adenine dinucleotide (NADH) in cellular energy metabolism and redox regulation. This article uniquely examines how NADH informs translational research, highlighting mechanistic depth, comparative assay insights, and evolving applications beyond conventional energy metabolism studies.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Enhanced Genome Editing Precision
2026-05-27
EZ Cap™ Cas9 mRNA (m1Ψ) enables highly efficient, low-immunogenicity CRISPR-Cas9 genome editing in mammalian cells, leveraging advanced Cap1 capping and m1Ψ modification for optimal specificity and translation. This APExBIO solution is designed for seamless integration into workflows requiring superior editing fidelity and is uniquely suited for research demanding both high performance and troubleshooting versatility.
453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page